• 1
    Watts RA, Scott DG. Classification and epidemiology of the vasculitides. Baillieres Clin Rheumatol 1997; 11: 191217.
  • 2
    Fauci AS, Haynes BF, Katz P, Wolff SM. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983; 98: 7685.
  • 3
    Koutantji M, Harrold E, Lane SE, Pearce S, Watts RA, Scott DG. Investigation of quality of life, mood, pain, disability, and disease status in primary systemic vasculitis. Arthritis Rheum 2003; 49: 82637.
  • 4
    Koutantji M, Pearce S, Harrold E. Psychological aspects of vasculitis. Rheumatology (Oxford) 2000; 39: 11739.
  • 5
    Lewis MA, Kalinowski CT, Sterba KR, Barrett TM, DeVellis RF. Interpersonal processes and vasculitis management. Arthritis Rheum 2006; 55: 6705.
  • 6
    Clark NM, Becker MH, Janz NK, Lorig K, Rakowski W, Anderson L. Self-management of chronic disease by older adults: a review and questions for research. J Aging Health 1991; 3: 327.
  • 7
    World Health Organization. Adherence to long-term therapies: evidence for action. Geneva: WHO Publications; 2003.
  • 8
    Gallant MP. The influence of social support on chronic illness self-management: a review and directions for research. Health Educ Behav 2003; 30: 17095.
  • 9
    Vasculitis Foundation. Patient information packet: Web version. 2003. URL:
  • 10
    Hoffman GS, Drucker Y, Cotch MF, Locker GA, Easley K, Kwoh K. Wegener's granulomatosis: patient-reported effects of disease on health, function, and income. Arthritis Rheum 1998; 41: 225762.
  • 11
    DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care 2002; 40: 794811.
  • 12
    Andrassy K, Erb A, Koderisch J, Waldherr R, Ritz E. Wegener's granulomatosis with renal involvement: patient survival and correlations between initial renal function, renal histology, therapy and renal outcome. Clin Nephrol 1991; 35: 13947.
  • 13
    Johnson SB. Methodological issues in diabetes research: measuring adherence. Diabetes Care 1992; 15: 165867.
  • 14
    Toobert DJ, Glasgow RE. Assessing diabetes self-management: the summary of diabetes self-care activities questionnaire. In: BradleyC, editor. Handbook of psychology and diabetes: a guide to psychological measurement in diabetes research and practice. Chur (Switzerland): Harwood Academic Publishers; 1994. p. 35175.
  • 15
    Bosworth HB, Weinberger M, Oddone EZ. Introduction. In: BosworthHB, OddoneEZ, WeinbergerM, editors. Patient treatment adherence: concepts, interventions, and measurement. Mahwah (NJ): Lawrence Erlbaum Associates; 2006. p. 311.
  • 16
    Jayne DR. Conventional treatment and outcome of Wegener's granulomatosis and microscopic polyangiitis. Cleve Clin J Med 2003; 69 Suppl 2: SII1105.
  • 17
    Hays RD. The Medical Outcomes Study (MOS) measures of patient adherence [serial online]. 1993. URL:
  • 18
    Kravitz RL, Hays RD, Sherbourne CD, DiMatteo MR, Rogers WH, Ordway L, et al. Recall of recommendations and adherence to advice among patients with chronic medical conditions. Arch Intern Med 1993; 153: 186978.
  • 19
    Keller SD, Bayliss MS, Ware JE Jr, Hsu M, Damiano AM, Goss TF. Comparison of responses to SF-36 Health Survey questions with one-week and four-week recall periods. Health Serv Res 1997; 32: 36784.
  • 20
    Hoffman GS, Langford CA. Are there different forms of life in the antineutrophil cytoplasmic antibody universe? Ann Intern Med 2005; 143: 6835.
  • 21
    Strahan R, Gerbasi K. Short, homogenous version of the Marlowe-Crowne Social Desirability Scale. J Clin Psychol 1972; 28: 1913.
  • 22
    Cattell RB. The scree test for the number of factors. Multivariate Behav Res 1966; 1: 24576.
  • 23
    Horn JL. A rationale and technique for estimating the number of factors in factor analysis. Psychometrika 1965; 30: 17985.
  • 24
    Fabrigar LR, Wegener DT, MacCallum RC, Strahan EJ. Evaluating the use of exploratory factor analysis in psychological research. Psychol Methods 1999; 4: 27299.
  • 25
    Hayton JC, Allen DG, Scarpello V. Factor retention decisions in exploratory factor analysis: a tutorial on parallel analysis. Organ Res Methods 2004; 7: 191205.
  • 26
    DeVellis RF. Scale development: theory and applications. 2nd ed. Thousand Oaks (CA): SAGE Publications; 2003.
  • 27
    Comrey AL, Lee HB. A first course in factor analysis. Hillsdale (NJ): Lawrence Erlbaum; 1992.
  • 28
    Pett MA, Lackey NR, Sullivan JJ. Making sense of factor analysis: the use of factor analysis for instrument development in health care research. Thousand Oaks (CA): SAGE Publications; 2003.
  • 29
    Weir JP. Quantifying test retest reliability using the intraclass correlation coefficient and the SEM. J Strength Cond Res 2005; 19: 23140.
  • 30
    Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979; 86: 4208.
  • 31
    Hogan SL, Falk RJ, Chin H, Cai J, Jennette CE, Jennette JC, et al. Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. Ann Intern Med 2005; 143: 62131.
  • 32
    Nunnally JC. Psychometric theory. 2nd ed. New York: McGraw-Hill; 1978.